Both procedures are done through AdiStem’s Fat Transfer modality.
Our own 1 year Clinical Trial results on Breast Augmentation, done in collaboration with a leading chain of Cosmetic Surgery centers in Seoul, Korea has shown:
1. Minimal resorption of graft tissue as opposed to the traditional volume loss of up to 60% in the first year;
2. Minimal inflammatory processes suggesting the presence of healthy cells unlike current procedures, and;
3. No reports of calcifications, scarring or other ill effects to date.
Similar encouraging 6 month results are also being seen in our own ongoing Clinical Trial at a leading centre for Breast Cancer in Bangkok, Thailand, for breast cancer survivors who had previously undergone Breast Lumpectomy and who have had no recurrence of cancer over 5 years.
About This Video
General Overview of Breast Augmentation
Video Description:
This is an overview of how AdiStem biotechnology and stem cell procedure are used in a breast augmentation.